Results
10464
Most Popular Stocks on the market
10,464 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AAPL | US$207.23 | -5.3% | 15.3% | US$3.2t | US$234.05 | PE30.9x | E7.7% | 0.5% | Tech | ||
MSFT | US$399.61 | -5.5% | 22.6% | US$2.9t | US$500.65 | PE33.7x | E12.5% | 0.8% | Software | ||
NVDA | US$104.25 | 0.5% | 133.4% | US$2.5t | US$156.46 | PE60.1x | E23.8% | 0.04% | Semiconductors | ||
GOOGL | US$158.29 | -7.0% | 20.5% | US$2.0t | US$204.04 | PE22.2x | E12.2% | 0.5% | Media | ||
AMZN | US$161.93 | -10.9% | 15.7% | US$1.7t | US$220.48 | PE38.3x | E19.9% | n/a | Retail | ||
META | US$494.09 | 4.1% | 61.9% | US$1.2t | US$564.40 | PE24.3x | E11.2% | 0.4% | Media | ||
BRK.A | US$633,175.00 | -4.4% | 14.5% | US$891.3b | US$702,750.00 | PE13.4x | E-18.9% | n/a | Diversified Financials | ||
LLY | US$793.18 | 0.4% | 52.1% | US$698.0b | US$920.45 | PE116.3x | E27.3% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$143.92 | 0.3% | 63.0% | US$661.4b | US$192.97 | PE65.5x | E28.4% | 1.5% | Semiconductors | ||
TSLA | US$200.64 | -9.9% | -19.6% | US$635.4b | US$203.79 | PE51.7x | E17.1% | n/a | Automobiles | ||
JPM | US$200.34 | -6.9% | 28.5% | US$554.5b | US$222.47 | PB1.8x | E-2.9% | 2.3% | Banks | ||
WMT | US$67.74 | -2.1% | 26.5% | US$543.7b | US$73.65 | PE28.8x | E7.0% | 1.2% | Consumer Retailing | ||
UNH | US$568.35 | -1.4% | 12.4% | US$524.6b | US$615.13 | PE37.1x | E23.4% | 1.5% | Healthcare | ||
XOM | US$114.16 | -3.4% | 6.0% | US$509.9b | US$132.81 | PE14.8x | E5.6% | 3.3% | Energy | ||
V | US$258.26 | -1.8% | 7.9% | US$487.8b | US$301.63 | PE26.1x | E9.6% | 0.8% | Diversified Financials | ||
MA | US$448.30 | 0.2% | 14.0% | US$408.3b | US$517.48 | PE33.8x | E11.8% | 0.6% | Diversified Financials | ||
PG | US$168.09 | 4.0% | 7.0% | US$395.6b | US$173.95 | PE26.6x | E6.4% | 2.4% | Household | ||
JNJ | US$158.97 | -1.5% | -8.2% | US$388.2b | US$170.67 | PE23.4x | E7.1% | 3.1% | Pharmaceuticals & Biotech | ||
COST | US$816.88 | 0.8% | 46.9% | US$355.5b | US$881.83 | PE50.5x | E7.4% | 0.6% | Consumer Retailing | ||
ORCL | US$128.21 | -5.5% | 11.3% | US$352.4b | US$148.92 | PE33.8x | E15.9% | 1.2% | Software | ||
HD | US$353.91 | -2.7% | 8.0% | US$347.1b | US$383.55 | PE23.6x | E5.3% | 2.5% | Retail | ||
ABBV | US$185.71 | -0.6% | 24.1% | US$325.6b | US$194.93 | PE61.9x | E26.0% | 3.3% | Pharmaceuticals & Biotech | ||
KO | US$68.05 | 0.5% | 11.7% | US$293.5b | US$70.09 | PE27.5x | E8.3% | 2.9% | Food, Beverage & Tobacco | ||
MRK | US$111.15 | -3.6% | 4.5% | US$284.7b | US$140.37 | PE20.5x | E14.3% | 2.8% | Pharmaceuticals & Biotech |